Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01935336
Title Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Colorado, Denver
Indications

lung cancer

Therapies

Ponatinib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST